speb/financial-data huggingface dataset:
ALZ.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -869000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1915000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2154000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -6087000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1500000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 700000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 33354000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Sale Of Business: 464000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 257692000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 821000000.00
ALZ.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 272000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 5160000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Share Issued: 386166676.00
ALZ.TO income_statement (annual, 2024-12-31) — Special Income Charges: -700000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 60287000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 41162000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -173600000.00
ALZ.TO income_statement (annual, 2024-12-31) — Tax Provision: 3476000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.25
ALZ.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 4679000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 4679000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Total Assets: 1044578000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 92534000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Total Debt: 34839000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Total Debt: 34839000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 64076000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Total Expenses: 125931000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 980502000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 4851000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 4851000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -700000000.00
ALZ.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -700000000.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 247239.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 247239.00
ALZ.TO balance_sheet (annual, 2024-12-31) — Treasury Stock: 38000000.00
ALZ.TO balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 38000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 26925000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 27732000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Amortization: 68000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: -2000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 7683620906.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.32
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1170000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 32620000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 32620000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 1170000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 62386000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 68000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 7685960827.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.31
ALZ.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 2421000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — EBIT: 3745000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 18908000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 190000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 190000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 62386000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 738766000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 738766000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Minority Interest: 3819000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Minority Interests: -158000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Net Income: 2423000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 2423000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 2581000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2423000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2423000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 2581000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -190000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -190000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 15542000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 43478000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 5556000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2174000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 2527546835.44
ALZ.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 26925000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 385551332.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 4814000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 153000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 18908000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1731000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Other Special Charges: 0.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 3555000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 68000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 144000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 35911000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 386166676.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -144000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 62386000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 43478000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -39453164.56
ALZ.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 974000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 1026857000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 62386000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 66205000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 23368000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 960652000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -144000000.00
ALZ.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -144000000.00
ALZ.TO balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 615344.00
ALZ.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 33090000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 9894000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 27732000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Amortization: 77000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 10490000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: -1000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2382000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1170000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 33886000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 590950000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 1170000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 57195000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 77000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 10899000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2701000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Financial Assets: 20649000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 98280000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 16475000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 18384000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 12988000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 83001000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Investment Properties: 22004000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 129419000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 707605000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2382000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 25806000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 28188000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 21122000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 3210000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 3673000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 3317000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Minority Interests: -177000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Net Income: 2841000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2702000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 3018000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2841000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2841000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 3018000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 12988000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: -1192000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 38811000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 903000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 5354000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2231000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 11519000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 2960189663.58
ALZ.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 33090000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 385551332.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 4630000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -7330000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1909000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -1579000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Other Payable: 980000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 5817000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 557064000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Other Special Charges: 0.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Payables: 6715000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1122000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 4102000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Properties: 3498000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 77000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 162000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 31739000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 385551332.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -162000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 57195000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 38811000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -42810336.42
ALZ.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 1084000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 4079000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 992884000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 83001000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 28188000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 60512000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 28988000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 932372000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 5735000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -162000000.00
ALZ.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -162000000.00
ALZ.TO balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 1055000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 39782000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 27732000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Amortization: 66000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: -1000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 7593820492.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.37
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1170000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 32079000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 32079000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 1170000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 60208000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 66000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 7594840922.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.37
ALZ.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2821000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — EBIT: 4188000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 18638000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 186000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 186000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 60208000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 748021000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 748021000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 3495000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Minority Interests: -163000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Net Income: 2847000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2822000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 3010000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2847000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2847000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 3010000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -186000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -186000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Net Policyholder Benefits And Claims: 15994000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 41570000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 4935000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2318000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 2956057971.01
ALZ.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 39782000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 380239760.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 4905000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 0.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 18638000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1725000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Other Special Charges: 0.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 25000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 4002000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 66000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 145000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 33602000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 386166676.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: -145000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 60208000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 41570000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -35942028.99
ALZ.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 992000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 1012773000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 60208000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 63703000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 35779000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 949070000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -145000000.00
ALZ.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -145000000.00
ALZ.TO balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 5926916.00
ALZ.TO income_statement (annual, 2025-12-31) — +Total Revenue: 137450000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 37858000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 7956000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 7956000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -14967000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -14967000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 27732000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 27732000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Amortization: 285000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Amortization: 67000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 11586000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 11586000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Average Dilution Earnings: -5000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Average Dilution Earnings: -1000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 7623332636.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 7568672664.00
ALZ.TO income_statement (annual, 2025-12-31) — Basic EPS: 1.39
ALZ.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.35
ALZ.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 31637000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -2265000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2453000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2453000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 1170000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1170000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 29855000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 29855000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 600102000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 600102000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -6387000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 7882000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 16000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 15359000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -466000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Common Stock: 1170000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 1170000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -6387000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 62722000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 62722000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1073000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -3062000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 375000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 375000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 375000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 375000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Depreciation: 2178000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2178000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 285000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 67000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 13568000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 13568000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 7625028940.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 7570073690.00
ALZ.TO income_statement (annual, 2025-12-31) — Diluted EPS: 1.39
ALZ.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.35
ALZ.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 10598000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2654000000.00
ALZ.TO income_statement (annual, 2025-12-31) — EBIT: 16218000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — EBIT: 3984000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -1362000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — End Cash Position: 29854000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Financial Assets: 24176000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Financial Assets: 24176000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 103036000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 103036000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -6778000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 30944000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -1401000000.00
ALZ.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 5340000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Goodwill: 16651000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 16651000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 18622000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 18622000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 28759000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 28759000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Interest Expense: 758000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 184000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 758000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 184000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Interest Income: 29014000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 95544000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 95544000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -26897000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Investment Properties: 21178000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Investment Properties: 21178000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 138798000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 138798000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 729022000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 729022000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 1073000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 8156000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2078000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2078000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 32822000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 32822000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 34900000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 34900000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 8156000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -6262000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 19977000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 19977000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 3274000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 3274000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 13127000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 13127000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 3627000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 3627000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Minority Interests: -655000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Minority Interests: -157000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 652000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -1989000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Net Debt: 2967000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 2967000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Net Income: 10775000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Net Income: 2664000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 10603000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2655000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 11430000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2820000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 10775000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2664000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 10775000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2664000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 11430000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 11430000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2820000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Net Interest Income: -758000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -184000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: 338000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -26150000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 1894000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 1894000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -758000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -184000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 95000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 365000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Net PPE: 13792000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 13792000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2102000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Net Policyholder Benefits And Claims: 37460000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Net Policyholder Benefits And Claims: 16809000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 44100000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 44100000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 795000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 795000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 5161000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 5161000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2436000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2436000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 11852000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 11852000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Normalized Income: 11318904000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 2861400000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 33209000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Operating Revenue: 137450000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 37858000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 380242198.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 380242198.00
ALZ.TO cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: 45000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Other Equity Interest: 4629000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 4629000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Other Income Expense: -7251000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 0.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1971000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1971000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 6705000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 356000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1803000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Other Payable: 1235000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 1235000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Other Properties: 11066000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 11066000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 570247000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 570247000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Other Special Charges: 0.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
ALZ.TO income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 172000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 9000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Payables: 7163000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Payables: 7163000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 942000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 942000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Pretax Income: 15460000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 3800000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Properties: 4566000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Properties: 4566000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: -1131000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -311142000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment Properties: -576000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2265000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2178000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 67000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -6262000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -3062000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 736000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 266000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 36275000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 36275000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 1783000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Sale Of Investment: 284992000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Sale Of Investment Properties: 914000000.00
ALZ.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 163000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 5340000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Share Issued: 380418897.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 380418897.00
ALZ.TO income_statement (annual, 2025-12-31) — Special Income Charges: -736000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: -266000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 62722000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 62722000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 44100000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 44100000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -192096000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -68600000.00
ALZ.TO income_statement (annual, 2025-12-31) — Tax Provision: 4030000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 980000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.26
ALZ.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
ALZ.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 4642000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 4642000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Total Assets: 1024276000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 1024276000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 95544000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 95544000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Total Debt: 35275000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 35275000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 66349000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 66349000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Total Expenses: 121990000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 34056000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 957927000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 957927000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 5928000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 5928000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -736000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -266000000.00
ALZ.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -736000000.00
ALZ.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -266000000.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 176699.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 176699.00
ALZ.TO balance_sheet (annual, 2025-12-31) — Treasury Stock: 32000000.00
ALZ.TO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 32000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 31065000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 27732000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Amortization: 66000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: -36000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 7568917667.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.49
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1170000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 27518000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 27518000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 1170000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 65900000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 66000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 7609449764.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.48
ALZ.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 3654000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — EBIT: 5305000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 18805000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 181000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 181000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 65900000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 758426000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 758426000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 3624000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Minority Interests: -156000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Net Income: 3690000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 3690000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3846000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3690000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3690000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3846000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -181000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -181000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 16213000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 47095000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 5454000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2328000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 3727529274.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 31065000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 379286270.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 4670000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 0.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 18805000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1720000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Other Special Charges: 0.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 5124000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 66000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 50000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 39593000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 380418897.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: -50000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 65900000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 47095000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -12470726.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 1278000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 1027101000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 65900000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 69524000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 25941000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 957577000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -50000000.00
ALZ.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -50000000.00
ALZ.TO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 1132627.00
ALZN income_statement (annual, 2022-04-30) — +Operating Expense: 12319535.00
ALZN income_statement (annual, 2022-04-30) — +Total Revenue: 0.00
ALZN balance_sheet (annual, 2022-04-30) — Accounts Payable: 1162850.00
ALZN balance_sheet (annual, 2022-04-30) — Additional Paid In Capital: 57419753.00
ALZN income_statement (annual, 2022-04-30) — Basic Average Shares: 65996.00
ALZN income_statement (annual, 2022-04-30) — Basic EPS: -189.00
ALZN cash_flow (annual, 2022-04-30) — Beginning Cash Position: 1929270.00
ALZN cash_flow (annual, 2022-04-30) — Capital Expenditure: -106458.00
ALZN balance_sheet (annual, 2022-04-30) — Capital Stock: 9548.00
ALZN balance_sheet (annual, 2022-04-30) — Cash And Cash Equivalents: 14063811.00
ALZN balance_sheet (annual, 2022-04-30) — Cash Cash Equivalents And Short Term Investments: 14063811.00
ALZN balance_sheet (annual, 2022-04-30) — Cash Financial: 14063811.00
ALZN cash_flow (annual, 2022-04-30) — Cash Flow From Continuing Financing Activities: 18854989.00
ALZN cash_flow (annual, 2022-04-30) — Cash Flow From Continuing Investing Activities: -106458.00
ALZN cash_flow (annual, 2022-04-30) — Cash Flow From Continuing Operating Activities: -6613990.00
ALZN cash_flow (annual, 2022-04-30) — Change In Payables And Accrued Expense: 693584.00
ALZN cash_flow (annual, 2022-04-30) — Change In Prepaid Assets: 633597.00
ALZN cash_flow (annual, 2022-04-30) — Change In Working Capital: 1327181.00
ALZN cash_flow (annual, 2022-04-30) — Changes In Cash: 12134541.00
ALZN balance_sheet (annual, 2022-04-30) — Common Stock: 9548.00
ALZN balance_sheet (annual, 2022-04-30) — Common Stock Equity: 13351511.00